BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rey-Jurado E, Kalergis AM. Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design. Int J Mol Sci 2017;18:E556. [PMID: 28273842 DOI: 10.3390/ijms18030556] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Vandini S, Biagi C, Lanari M. Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection. Int J Mol Sci 2017;18:E1717. [PMID: 28783078 DOI: 10.3390/ijms18081717] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
2 Jansen KU, Gruber WC, Simon R, Wassil J, Anderson AS. The impact of human vaccines on bacterial antimicrobial resistance. A review. Environ Chem Lett 2021;:1-32. [PMID: 34602924 DOI: 10.1007/s10311-021-01274-z] [Reference Citation Analysis]
3 Bianchini S, Silvestri E, Argentiero A, Fainardi V, Pisi G, Esposito S. Role of Respiratory Syncytial Virus in Pediatric Pneumonia. Microorganisms 2020;8:E2048. [PMID: 33371276 DOI: 10.3390/microorganisms8122048] [Reference Citation Analysis]
4 Acevedo OA, Díaz FE, Beals TE, Benavente FM, Soto JA, Escobar-Vera J, González PA, Kalergis AM. Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus. Front Cell Infect Microbiol 2019;9:75. [PMID: 30984626 DOI: 10.3389/fcimb.2019.00075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
5 Gao Y, Cao J, Xing P, Altmeyer R, Zhang Y. Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro. Molecules 2021;26:2607. [PMID: 33946996 DOI: 10.3390/molecules26092607] [Reference Citation Analysis]
6 Lin L, An L, Chen H, Feng L, Lu M, Liu Y, Chu C, Shan J, Xie T, Wang X, Wang S. Integrated Network Pharmacology and Lipidomics to Reveal the Inhibitory Effect of Qingfei Oral Liquid on Excessive Autophagy in RSV-Induced Lung Inflammation. Front Pharmacol 2021;12:777689. [PMID: 34925035 DOI: 10.3389/fphar.2021.777689] [Reference Citation Analysis]
7 Shen C, Zhang Z, Xie T, Xu J, Yan J, Kang A, Dai Q, Wang S, Ji J, Shan J. Jinxin oral liquid inhibits human respiratory syncytial virus-induced excessive inflammation associated with blockade of the NLRP3/ASC/Caspase-1 pathway. Biomedicine & Pharmacotherapy 2018;103:1376-83. [DOI: 10.1016/j.biopha.2018.04.174] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
8 Noor F, Ali Ashfaq U, Rizwan Javed M, Hamzah Saleem M, Ahmad A, Farhan Aslam M, Aslam S. Comprehensive computational analysis reveals human respiratory syncytial virus encoded microRNA and host specific target genes associated with antiviral immune responses and protein binding. Journal of King Saud University - Science 2021;33:101562. [DOI: 10.1016/j.jksus.2021.101562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Van Lam van T, Ivanova T, Hardes K, Heindl MR, Morty RE, Böttcher-Friebertshäuser E, Lindberg I, Than ME, Dahms SO, Steinmetzer T. Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin. ChemMedChem 2019;14:673-85. [PMID: 30680958 DOI: 10.1002/cmdc.201800807] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
10 Simancas-Racines D, Franco JV, Guerra CV, Felix ML, Hidalgo R, Martinez-Zapata MJ. Vaccines for the common cold. Cochrane Database Syst Rev 2017;5:CD002190. [PMID: 28516442 DOI: 10.1002/14651858.CD002190.pub5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
11 Mathew S, Taleb S, Eid AH, Althani AA, Yassine HM. In silico virtual screening of lead compounds for major antigenic sites in respiratory syncytial virus fusion protein. Emergent Mater 2021;:1-11. [PMID: 33969268 DOI: 10.1007/s42247-021-00213-6] [Reference Citation Analysis]
12 Espinoza JA, León MA, Céspedes PF, Gómez RS, Canedo-Marroquín G, Riquelme SA, Salazar-Echegarai FJ, Blancou P, Simon T, Anegon I, Lay MK, González PA, Riedel CA, Bueno SM, Kalergis AM. Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection. J Immunol 2017;199:212-23. [PMID: 28566367 DOI: 10.4049/jimmunol.1601414] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
13 Schultz BM, Acevedo OA, Kalergis AM, Bueno SM. Role of Extracellular Trap Release During Bacterial and Viral Infection. Front Microbiol 2022;13:798853. [PMID: 35154050 DOI: 10.3389/fmicb.2022.798853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Narayanan S, Elesela S, Rasky AJ, Morris SH, Kumar S, Lombard D, Lukacs NW. ER stress protein PERK promotes inappropriate innate immune responses and pathogenesis during RSV infection. J Leukoc Biol 2021. [PMID: 33866604 DOI: 10.1002/JLB.3A0520-322RR] [Reference Citation Analysis]
15 Resch B. Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection. Hum Vaccin Immunother 2017;13:2138-49. [PMID: 28605249 DOI: 10.1080/21645515.2017.1337614] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 11.6] [Reference Citation Analysis]
16 Ptaschinski C, Lukacs NW. Early Life Respiratory Syncytial Virus Infection and Asthmatic Responses. Immunol Allergy Clin North Am 2019;39:309-19. [PMID: 31284922 DOI: 10.1016/j.iac.2019.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Taleb SA, Al Thani AA, Al Ansari K, Yassine HM. Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches. Eur J Clin Microbiol Infect Dis 2018;37:1817-27. [PMID: 29876771 DOI: 10.1007/s10096-018-3289-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
18 Jansen KU, Knirsch C, Anderson AS. The role of vaccines in preventing bacterial antimicrobial resistance. Nat Med 2018;24:10-9. [DOI: 10.1038/nm.4465] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 24.3] [Reference Citation Analysis]